StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
41
This month
1
This year
2
Publishing Date
2024 - 04 - 11
1
2024 - 03 - 05
1
2023 - 10 - 23
2
2023 - 10 - 20
1
2023 - 10 - 13
1
2023 - 09 - 26
1
2023 - 09 - 19
1
2023 - 06 - 08
1
2023 - 06 - 05
1
2023 - 05 - 31
1
2023 - 05 - 25
1
2023 - 04 - 26
1
2023 - 03 - 24
1
2022 - 12 - 01
1
2022 - 11 - 21
1
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 11 - 07
1
2022 - 10 - 05
1
2022 - 06 - 28
1
2022 - 05 - 04
1
2022 - 05 - 02
1
2022 - 03 - 31
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 02
1
2022 - 01 - 27
1
2022 - 01 - 24
1
2022 - 01 - 20
1
2022 - 01 - 14
1
2021 - 12 - 10
3
2021 - 11 - 19
1
2021 - 11 - 03
2
2021 - 10 - 14
1
2021 - 09 - 20
1
2021 - 05 - 20
2
Sector
Consumer services
1
Health technology
41
Professional, scientific, and technical services
3
Tags
Alliances
2
America
1
Artificial intelligence
1
Asco
4
Award
1
Biocanada
21
Biomarkers
2
Biotech
85
Biotech-beach
2
Breast
6
Breast cancer
9
Cancer
41
Cancer drug
1
Cel
1
Ces
1
Chinese
3
Clinical-trials-phase-ii
4
Companies
1
Conference
19
Designation
1
Drug
1
Earnings
4
Ema
2
Enroll
1
Events
8
Fast track designation
2
Fda
5
Financial
12
Financial results
7
For
1
Gastrointestinal
4
Glioblastoma
1
Growth
3
Immunotherapy
2
Iot
31
Meeting
11
N/a
48
Negative
2
Pancreas
2
Pancreatic
14
People
2
Phase 1
6
Phase 2
2
Phase 2b
2
Positive
8
Potential
2
Pre-clinical
5
Preclinical
5
Presentation
9
Research
7
Response
3
Results
26
Study
4
Success
2
Symposium
5
Test
3
Therapy
6
Treatment
9
Trial
14
Year
5
Entities
Accuray incorporated
1
Amgen inc.
1
Astrazeneca plc
3
Athenex, inc.
1
Beigene, ltd.
1
Biontech se
3
Briacell therapeutics corp.
2
Bristol-myers squibb company
3
Clovis oncology, inc.
1
Cytomx therapeutics, inc.
1
Eli lilly and company
2
Exact sciences corporation
1
Geron corporation
1
Gilead sciences, inc.
1
Glaxosmithkline plc
1
Hologic, inc.
2
Illumina, inc.
1
Immunogen, inc.
1
In8bio inc
1
Incyte corporation
2
Iteos therapeutics, inc.
1
Jazz pharmaceuticals plc
1
Marker therapeutics, inc.
1
Merck & company, inc.
3
Merrimack pharmaceuticals, inc.
1
Merus n.v.
1
Mirati therapeutics, inc.
2
Myriad genetics, inc.
1
Nektar therapeutics
1
Novartis ag
1
Oncolytics biotech inc.
41
Pfizer, inc.
2
Precigen, inc.
1
Pyxis oncology inc
1
Relay therapeutics, inc.
1
Sanofi
1
Seagen inc.
1
Seelos therapeutics, inc.
1
Veracyte, inc.
1
Symbols
A
27
ABBV
53
ABT
48
ALPMF
49
ALPMY
49
AMGN
91
ANIX
48
ARAY
26
AVEO
24
AZN
144
AZNCF
74
BCTX
50
BDX
26
BGNE
58
BIOC
31
BMY
107
BPMC
27
CLVS
33
CSTL
28
EXAS
56
EXEL
43
FNCTF
138
GH
53
GILD
59
GLAXF
46
GNPX
26
GSK
54
GTHX
27
HOLX
32
HOTH
29
IBRX
29
ILMN
68
IMGN
25
IMMP
34
INCY
57
JAGX
36
JNJ
138
KPTI
27
LLY
139
LTRN
24
MRK
75
MRTX
32
MYGN
50
NTRA
38
NVCR
30
NVS
106
NVSEF
91
NVTA
25
ONCY
41
PDSB
34
PFE
66
QGEN
31
REGN
42
SGEN
55
SNY
215
SNYNF
165
TAK
34
TMO
51
VCYT
45
VSTM
25
Exchanges
Nasdaq
41
Nyse
8
Crawled Date
2024 - 04 - 11
1
2024 - 03 - 05
1
2023 - 10 - 23
2
2023 - 10 - 20
1
2023 - 10 - 13
1
2023 - 09 - 26
1
2023 - 09 - 19
1
2023 - 06 - 08
1
2023 - 06 - 05
1
2023 - 05 - 31
1
2023 - 05 - 25
1
2023 - 04 - 27
1
2023 - 03 - 24
1
2022 - 12 - 01
1
2022 - 11 - 21
1
2022 - 11 - 14
1
2022 - 11 - 10
1
2022 - 11 - 07
1
2022 - 10 - 05
1
2022 - 06 - 28
1
2022 - 05 - 04
1
2022 - 05 - 02
1
2022 - 03 - 31
1
2022 - 03 - 24
1
2022 - 03 - 17
1
2022 - 02 - 02
1
2022 - 01 - 27
1
2022 - 01 - 24
1
2022 - 01 - 20
1
2022 - 01 - 14
1
2021 - 12 - 10
3
2021 - 11 - 19
1
2021 - 11 - 03
2
2021 - 10 - 14
1
2021 - 09 - 20
1
2021 - 05 - 20
2
Crawled Time
00:00
1
11:00
4
12:00
8
12:20
1
12:30
2
13:00
6
13:20
2
14:00
2
14:20
1
14:30
2
15:00
1
16:00
2
17:00
5
19:00
2
22:00
2
Source
www.biospace.com
18
www.prnewswire.com
23
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
symbols :
ONCY
save search
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published:
2024-04-11
(Crawled : 12:00)
- biospace.com/
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
1.85%
|
O:
1.85%
H:
0.0%
C:
0.0%
biotech
fda
breast
cancer
for
meeting
trial
submission
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Published:
2024-03-05
(Crawled : 12:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
19.57%
|
O:
6.52%
H:
6.12%
C:
5.1%
biotech
cancer
pancreatic
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Published:
2023-10-23
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-29.03%
|
O:
0.65%
H:
9.94%
C:
8.33%
success
cancer
study
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Published:
2023-10-23
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-29.03%
|
O:
0.65%
H:
9.94%
C:
8.33%
positive
cancer
pancreatic
study
Biotech Companies Make Further Progress in Promising Pancreatic Cancer Treatment Research
Published:
2023-10-20
(Crawled : 14:30)
- prnewswire.com
SGEN
|
$228.74
0.1%
20M
|
Health Technology
|
6.41%
|
O:
0.15%
H:
0.0%
C:
0.0%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-32.1%
|
O:
-1.85%
H:
3.14%
C:
-2.52%
MYGN
|
News
F
|
$18.64
-1.48%
-1.39%
550K
|
Health Technology
|
27.15%
|
O:
0.41%
H:
3.13%
C:
2.38%
ILMN
|
$118.29
0.51%
0.52%
1.6M
|
Health Technology
|
-1.41%
|
O:
0.02%
H:
0.94%
C:
-0.3%
BNTX
|
$86.4
0.07%
0.09%
1.2M
|
Health Technology
|
-7.4%
|
O:
-1.46%
H:
0.48%
C:
-1.06%
companies
biotech
cancer
pancreatic
treatment
research
New FDA Designations Accelerate Progress in Pancreatic Cancer Treatments: A Year in Review
Published:
2023-10-13
(Crawled : 13:00)
- prnewswire.com
PYXS
|
$4.83
2.99%
3.2%
590K
|
Professional, Scientific, and T...
|
147.69%
|
O:
0.0%
H:
2.56%
C:
2.56%
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
23.38%
|
O:
1.15%
H:
0.0%
C:
0.0%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-40.22%
|
O:
-1.63%
H:
4.97%
C:
2.76%
MRUS
|
$41.05
1.84%
1.71%
410K
|
Health Technology
|
94.73%
|
O:
0.47%
H:
1.7%
C:
-0.38%
AZN
|
$68.53
0.39%
0.39%
3.2M
|
Health Technology
|
0.23%
|
O:
-0.59%
H:
0.62%
C:
-0.56%
fda
year
review
cancer
pancreatic
THE PANCREATIC CANCER ACTION NETWORK SELECTS ONCOLYTICS BIOTECH® INC. TO RECEIVE $5 MILLION THERAPEUTIC ACCELERATOR AWARD TO DEVELOP LEADING-EDGE TREATMENTS
Published:
2023-09-26
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-48.36%
|
O:
0.0%
H:
5.63%
C:
4.69%
biotech
award
cancer
pancreatic
network
Pancreatic Cancer Battle Boosted by $200M VC Firm
Published:
2023-09-19
(Crawled : 17:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-46.08%
|
O:
-1.47%
H:
4.98%
C:
3.98%
MRTX
|
$58.7
-0.17%
0.34%
0
|
Health Technology
|
84.91%
|
O:
-0.13%
H:
2.0%
C:
1.83%
MACK
4
|
$14.68
0.0%
100K
|
Health Technology
|
19.93%
|
O:
-0.41%
H:
0.9%
C:
0.74%
INCY
|
$52.72
-0.94%
-0.91%
2.1M
|
Health Technology
|
-11.41%
|
O:
0.03%
H:
2.18%
C:
1.8%
BNTX
|
$86.4
0.07%
0.09%
1.2M
|
Health Technology
|
-20.82%
|
O:
-0.01%
H:
1.99%
C:
1.28%
cancer
pancreatic
New Drugs in Fight Against Cancer Being Powered by Novel Mechanisms of Action
Published:
2023-06-08
(Crawled : 22:00)
- biospace.com/
GSK
|
$39.6
-0.88%
0.03%
2.6M
|
Health Technology
|
15.25%
|
O:
0.41%
H:
0.68%
C:
0.64%
PGEN
|
$1.31
-3.68%
-3.42%
810K
|
Health Technology
|
-0.76%
|
O:
0.0%
H:
0.76%
C:
-4.55%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-30.82%
|
O:
0.63%
H:
1.87%
C:
-1.25%
ITOS
|
$10.68
-3.78%
-3.93%
200K
|
Health Technology
|
-31.23%
|
O:
-0.52%
H:
3.23%
C:
-2.2%
GILD
|
$66.93
-0.57%
-0.55%
3.8M
|
Health Technology
|
-12.03%
|
O:
-0.42%
H:
3.56%
C:
3.48%
cancer
Oncolytics Biotech® Announces Updated Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial that Show Pelareorep Driving Robust Increases in Progression-Free Survival and Confirmed Overall Response Rate
Published:
2023-06-05
(Crawled : 11:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-36.05%
|
O:
-1.74%
H:
2.96%
C:
-2.96%
biotech
breast
cancer
trial
response
show
Big Developments in Cancer Treatments set for Upcoming ASCO 2023 Annual Meeting in June
Published:
2023-05-31
(Crawled : 16:00)
- biospace.com/
INAB
|
$1.0
2.01%
3.89%
170K
|
|
-65.28%
|
O:
0.35%
H:
6.57%
C:
5.19%
VCYT
|
$18.86
-0.32%
-0.26%
660K
|
Health Technology
|
-26.56%
|
O:
-0.43%
H:
3.05%
C:
1.21%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-36.05%
|
O:
0.0%
H:
0.0%
C:
-5.81%
JAZZ
|
News
|
$107.1
-1.65%
-1.63%
590K
|
Health Technology
|
-15.56%
|
O:
-0.09%
H:
2.57%
C:
1.13%
GERN
|
$3.68
2.79%
2.98%
5.3M
|
Health Technology
|
10.84%
|
O:
0.6%
H:
2.1%
C:
-2.1%
asco
cancer
meeting
set
Oncolytics Biotech® Announces Positive Randomized Phase 2 Data from BRACELET-1 Metastatic Breast Cancer Trial Demonstrating Pelareorep Drives ≥50% Improvements in ORR and mPFS in an ASCO Annual Meeting Abstract
Published:
2023-05-25
(Crawled : 22:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-49.07%
|
O:
-0.93%
H:
0.0%
C:
-18.22%
biotech
breast
asco
positive
cancer
meeting
trial
Oncolytics Biotech® Announces Upcoming Oral Presentation on Randomized BRACELET-1 Trial in HR+/HER2- Metastatic Breast Cancer at the ASCO Annual Meeting
Published:
2023-04-26
(Crawled : 00:00)
- biospace.com/
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-2.65%
|
O:
-0.88%
H:
15.18%
C:
13.39%
biotech
breast
presentation
asco
cancer
meeting
trial
Evolution of Oncology Treatments Giving New Hope to Those Diagnosed with Breast Cancer
Published:
2023-03-24
(Crawled : 13:20)
- prnewswire.com
RLAY
|
$6.21
-7.86%
-8.36%
1.9M
|
Health Technology
|
-59.88%
|
O:
-0.71%
H:
0.72%
C:
-0.39%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-11.29%
|
O:
0.81%
H:
0.0%
C:
-3.2%
HOLX
|
$74.92
-0.25%
-0.27%
1.3M
|
Health Technology
|
-4.6%
|
O:
-0.04%
H:
1.03%
C:
0.89%
CTMX
|
$1.76
-5.38%
-5.38%
590K
|
Health Technology
|
10.06%
|
O:
0.59%
H:
1.76%
C:
0.0%
BCTX
|
$2.19
-5.6%
-5.94%
140K
|
Professional, Scientific, and T...
|
-59.65%
|
O:
-0.58%
H:
2.65%
C:
2.06%
breast
hope
cancer
Oncolytics Biotech® Receives FDA Fast Track Designation for the Treatment of Advanced/Metastatic Pancreatic Cancer
Published:
2022-12-01
(Crawled : 13:00)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-37.5%
|
O:
5.11%
H:
23.24%
C:
14.59%
biotech
treatment
fda
designation
cancer
pancreatic
fast track designation
Oncolytics Biotech® Announces Presentations at the Upcoming San Antonio Breast Cancer Symposium
Published:
2022-11-21
(Crawled : 15:00)
- biospace.com/
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-21.43%
|
O:
0.0%
H:
3.57%
C:
-3.93%
biotech
breast
symposium
cancer
Biotech Sector Gaining Wins Against Pancreatic Cancer with Early Detection and New Therapies
Published:
2022-11-14
(Crawled : 16:00)
- prnewswire.com
LLY
|
News
|
$750.77
0.54%
0.22%
2.8M
|
Health Technology
|
113.11%
|
O:
1.92%
H:
0.48%
C:
-0.84%
BMY
|
$47.84
-0.87%
0.48%
9.9M
|
Health Technology
|
-36.47%
|
O:
0.83%
H:
1.63%
C:
-0.26%
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-33.33%
|
O:
3.64%
H:
0.58%
C:
-7.6%
BNTX
|
$86.4
0.07%
0.09%
1.2M
|
Health Technology
|
-44.12%
|
O:
-1.61%
H:
6.39%
C:
5.49%
biotech
cancer
pancreatic
Oncolytics Biotech® Presents Updated Clinical Data at SITC Annual Meeting Showing a 69% Objective Response Rate and Confirmed Complete Response in GOBLET Study's Pancreatic Cancer Cohort
Published:
2022-11-10
(Crawled : 14:20)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-38.2%
|
O:
5.06%
H:
6.42%
C:
4.81%
biotech
meeting
response
cancer
pancreatic
Oncolytics Biotech® Reports Interim Results from Phase 1/2 GOBLET Study Showing a 70% Objective Response Rate in Pancreatic Cancer at the SITC Annual Meeting
Published:
2022-11-07
(Crawled : 13:20)
- prnewswire.com
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-12.7%
|
O:
9.52%
H:
10.87%
C:
8.7%
biotech
meeting
response
results
cancer
study
pancreatic
phase 1
Oncolytics Biotech® Announces Upcoming Presentations at the Society for Immunotherapy of Cancer 37th Annual Meeting
Published:
2022-10-05
(Crawled : 17:00)
- biospace.com/
ONCY
|
$1.045
-3.24%
-3.35%
180K
|
Health Technology
|
-15.38%
|
O:
0.77%
H:
0.76%
C:
-3.05%
biotech
immunotherapy
meeting
cancer
← Previous
1
2
3
Next →
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0373
62.88%
37.26%
460M
|
Health Technology
WISA
4
|
$9.25
51.64%
34.27%
64M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.29
33.92%
26.61%
1.8M
|
Health Technology
TIRX
|
$0.4848
7.49%
24.58%
5.9M
|
SRFM
4
|
$0.3859
-12.3%
23.84%
660K
|
n/a
KZIA
|
$0.3442
18.28%
23.42%
290K
|
Health Technology
CTM
|
$0.2201
-2.31%
22.67%
48K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.